Medicine Description atometaflozine 12.5 mg / 1000 mg
atometaflozine 30 f.c. tablets is a medication that combines empagliflozin and metformin, utilized primarily for managing type 2 diabetes. Empagliflozin operates by inhibiting the sodium-glucose co-transporter 2 (SGLT2) in the renal proximal tubules, which results in decreased glucose reabsorption from the renal filtrate back into the bloodstream. This action facilitates increased glucose excretion in the urine, thereby lowering blood glucose levels. Simultaneously, metformin enhances insulin sensitivity, promoting improved uptake of glucose by peripheral tissues, particularly muscle, and reduces hepatic glucose production. Together, these mechanisms effectively contribute to better glycemic control.
Indications and Uses of atometaflozine 30 f.c. tablets
- Management of type 2 diabetes mellitus in adults
- Improvement of glycemic control in conjunction with diet and exercise
Side Effects of atometaflozine 30 f.c. tablets
- Nausea
- Diarrhea
- Abdominal pain
- Dehydration
- Urinary tract infections
- Hypoglycemia
Storage and Handling
Store at room temperature, away from moisture and heat. Keep the medication in its original packaging, tightly closed, and out of reach of children.
Patient Advice and Precautions
Patients should adhere to their prescribed lifestyle changes, including diet and exercise. Regular monitoring of blood glucose levels is crucial. Inform healthcare providers of any existing kidney issues or dehydration. Be cautious of potential interactions with other medications and consult a healthcare professional before starting new treatments.